CS Interpharm General Trading Co. LLC

Insider Reports History

Location
Dubai
Signature
/s/ Mohammad Essayed
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CS Interpharm General Trading Co. LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
CS DIAGNOSTICS CORP. 10%+ Owner Common Stock 42,560,096 31 Dec 2025 Direct

Insider Reports Filed by CS Interpharm General Trading Co. LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CSDX CS DIAGNOSTICS CORP. 31 Dec 2025 0 $0 3 10%+ Owner 04 Feb 2026, 14:00